Stakeholder

Stakeholder Engagement for Identifying Material Topics and Communication Frequency

The Corporate Governance Officer reports the communications with stakeholders to the Board of Directors annually. The communications with stakeholders including feedbacks from stakeholders, responses and follow-up response plans have been reported to the Board of Directors on August 7, 2024.

Stakeholders	Main party	Key Focus Areas	Responses	Communication Performance in 2024
Shareholders/ Investors	Institutional shareholders Individual shareholders	Business Ethics Legal compliance and ethical corporate Operating Risk, Risk Management Sustainable Governance Operations Economic Performance New drug R&D and innovation	Spokesperson and mailbox Company website Investor conference Shareholders’ meeting Board of Directors	✓ Held 4 investor conferences ✓ Held 1 shareholders’ meeting and 6 Board meetings ✓ Shareholders exercised their voting rights by electronic means to fully participate in the voting on proposals ✓ Prepared the annual report for the shareholders’ meeting and announcement for investors’ reference
Employees	All Employees	Occupational Safety and Health Management Well-being and Inclusive Workplace Diversity and Equal Opportunities Talent Development and Training Labor-Management Relations Business Ethics Human Rights	Labor-Management meeting Departmental meeting Interdepartmental meeting Employee Welfare Committee	✓ Quarterly labor-management meetings ✓ Biannual Plan of Action (POA) meetings ✓ Regularly held departmental meetings(monthly) ✓ Held 8 Employee Welfare Committee ✓ PDP performance management interviews (initial/mid-term/final) ✓ Annual Individual Development Plans (IDP) setup and feedback
Clients	Healthcare professionals Patients Agents	New drug R&D and innovation Quality and safety management of medicines Drug Distribution and Pricing Customer Privacy Physician-Patient Relationship and Social Participation	Seminars Visits	✓ Periodic large-scale workshops ✓ Freephone number ✓ Irregular meetings ✓ Education and training
Suppliers and Contractors	Raw material suppliers Outsourced manufacturers Pharmaceutical warehousing and logistics Transport distribution companies General service suppliers	Business Ethics Regulatory Compliance and Integrity in Operations Economic Performance New Drug Research and Innovation Supply Chain Management	Emails Visits Production and sales meetings	✓ Monthly regular meetings ✓ Annual and triennial evaluations for existing suppliers ✓ Auditing of new suppliers ✓ Phone and email
Media outlets	General public	Economic Performance New Drug Research and Innovation Drug Quality and Safety Management Doctor-Patient Relations & Social Engagement Drug Distribution and Pricing Customer Privacy	Visits Emails	✓ Irregular annual press ✓ luncheons for financial disclosures ✓ Occasional media visits and luncheons ✓ Press releases for important announcements ✓ Communication via phone and email
Competent Authorities	Government	Climate Change Chemical Substance Management Ecological Impact Labor/management relations Legal compliance and ethical corporate management Information Security Air pollution management Water resources management Waste management	Official letter correspondence Promotion of policies and relevant systems	✓ Financial reports ✓ Market Observation Post System (MOPS) ✓ Irregular audits ✓ Participated in awareness raising events

Investors and Shareholders

Spokesperson: Ted Kao

Title: Chief Financial Officer

Phone: 02-2655-8525 #5154

Email: ted_kao@tshbiopharm.com

Deputy Spokesperson and Investor Relations Contact: Shuping Huang

Title: Manager of Administration Department

Phone: 02-2655-8525 #5105

Email: Shupinghuang@tshbiopharm.com

Whistleblowing- Ethical Management Promotion Team

Email: ethical@tshbiopharm.com

Internal Whistleblowing

Contact: Jessica Wu

Title: Chief Internal Auditor

Phone: 02-2655-8525 #5523

Email: Jessica_wu@tshbiopharm.com

Collaboration

Contact: Han Hsieh

Title: Director of Corporate Development and Research

Phone: 02-2655-8525 #5412

Email: han_hsieh@tshbiopharm.com

Suppliers

Contact: Eliza Chang

Title: Senior Specialist

Phone: 02-2655-8525 #5131

Email: eliza@tshbiopharm.com

Public Relations and Sustainable Development

Contact: Isa Wang

Title: Assistant Manager

Phone: 02-2655-8525 #5111

Email: isa_wang@tshbiopharm.com

Menu